Investor relations

Investor relations is only available in Swedish

Prolight Diagnostics as an investment

Increased demand for safe POC tests

The covid pandemic has increased the demand for safe POC testing that can be performed close to the patient.

We fill a need in the market

The ambition is to offer the market innovative analyses via POC testing, with the same high precision as central laboratories, but with shortened analysis time.

Correct diagnosis streamlines care

Shorter analysis times and faster analysis results result in safer patient priorities and better patient flow. In this way, healthcare is able to save time, money and resources.

Read More.

With the potential to test more biomarkers and multiplexes

In negotiation with several industry partners regarding the company's POC platform, requests have been made to include more biomarkers in order to be able to test more markers at the same time, so-called multiplex.

Read More.